Longitudinal Pharmacokinetic, Pharmacodynamic, Immunological, and Biochemical

CompletedOBSERVATIONAL
Enrollment

229

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions
Multiple Sclerosis
Trial Locations (1)

84103

Rocky Mountain Multiple Sclerosis Clinic, Salt Lake City

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Biogen

INDUSTRY

lead

John F. Foley, MD

OTHER

NCT01330498 - Longitudinal Pharmacokinetic, Pharmacodynamic, Immunological, and Biochemical | Biotech Hunter | Biotech Hunter